文献速递心脑血管急症重症综合管理与镇静镇痛

重型创伤性脑损伤患者血清钠浓度变异性及其预后意义:一项多中心观察性研究

Variability in Serum Sodium Concentration and Prognostic Significance in Severe Traumatic Brain Injury: A Multicenter Observational Study.
PubMed 文献 · Neurocrit Care · 2020-10-02
一句话结论重型TBI患者入住ICU前7天每日血清钠标准差是28天死亡率的独立预测因子(HR 1.27,95%CI 1.01–1.61)。

该多中心观察性研究纳入欧洲和澳大利亚14个神经创伤ICU的240例重型TBI患者,采集入住ICU前7天每6小时血清钠水平,评估每日血清钠标准差(dNaSD)与28天死亡率的关系。患者年龄46±19岁,初始GCS中位数6[4-8],总体住院死亡率28%,高钠血症和低钠血症发生率分别为64%和24%。校正基线TBI严重程度、尿崩症、渗透治疗、高钠/低钠血症发生及中心后,dNaSD与28天死亡率独立相关(HR 1.27,95%CI 1.01-1.61,p=0.048)。

要点

  • 重型TBI患者入住ICU前7天每日血清钠标准差(dNaSD)与28天死亡率独立相关(HR 1.27,95%CI 1.01-1.61,p=0.048)。
  • 该研究纳入14个神经创伤ICU的240例重型TBI患者(初始GCS中位数6[4-8]),总体住院死亡率28%。
  • 高钠血症发生率为64%,低钠血症发生率为24%;前7天血清钠标准差为2.8[2.0-3.9] mmol/L。
  • 最大每日血清钠标准差出现在入院后中位2[1-4]天,前7天dNaSD呈显著进行性下降(系数-0.15,95%CI -0.18至-0.12,p<0.001)。

适用人群与场景

  • 欧洲和澳大利亚14个神经创伤ICU收治的重型创伤性脑损伤患者,共240例,年龄46±19岁,初始GCS中位数6[4-8]。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 多中心观察性研究,纳入14个神经创伤ICU的240例重型TBI患者,采集入住ICU前7天每6小时血清钠水平。
  • 主要终点:校正基线TBI严重程度、尿崩症、渗透治疗、高钠血症和低钠血症发生及中心后,每日血清钠标准差(dNaSD)与28天死亡率独立相关(HR 1.27,95%CI 1.01-1.61,p=0.048)。
  • 总体住院死亡率28%;高钠血症发生率64%,低钠血症发生率24%。
  • 前7天血清钠标准差为2.8[2.0-3.9] mmol/L;最大dNaSD出现在入院后中位2[1-4]天;前7天dNaSD呈显著进行性下降(系数-0.15,95%CI -0.18至-0.12,p<0.001)。

证据类型、等级与局限

  • 多中心观察性研究;原文未给出证据等级或推荐强度。
  • 原文述局限性:需要进一步前瞻性研究在更大TBI队列中确认钠变异性意义,并检验减弱这种变异性是否带来结局获益。

对床旁实践的改变

  • 该研究提示重型TBI患者入住ICU前7天每日血清钠变异性(dNaSD)是28天死亡率的独立预测因子,可能有助于床旁风险分层。
  • 原文结论指出需进一步前瞻性研究确认钠变异性在更大TBI队列中的意义,并检验减弱这种变异性是否带来结局获益。

指南或共识出处

  • Variability in Serum Sodium Concentration and Prognostic Significance in Severe Traumatic Brain Injury: A Multicenter Observational Study(Neurocrit Care)。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND/OBJECTIVE: Dysnatremia is common in severe traumatic brain injury (TBI) patients and may contribute to mortality. However, serum sodium variability has not been studied in TBI patients. We hypothesized that such variability would be independently associated with mortality.

METHODS: We collected 6-hourly serum sodium levels for the first 7 days of ICU admission from 240 severe TBI patients in 14 neurotrauma ICUs in Europe and Australia. We evaluated the association between daily serum sodium standard deviation (dNaSD), an index of variability, and 28-day mortality.

RESULTS: Patients were 46 ± 19 years of age with a median initial GCS of 6 [4-8]. Overall hospital mortality was 28%. Hypernatremia and hyponatremia occurred in 64% and 24% of patients, respectively. Over the first 7 days in ICU, serum sodium standard deviation was 2.8 [2.0-3.9] mmol/L. Maximum daily serum sodium standard deviation (dNaSD) occurred at a median of 2 [1-4] days after admission. There was a significant progressive decrease in dNaSD over the first 7 days (coefficient - 0.15 95% CI [- 0.18 to - 0.12], p < 0.001). After adjusting for baseline TBI severity, diabetes insipidus, the use of osmotherapy, the occurrence of hypernatremia, and hyponatremia and center, dNaSD was significantly independently associated with 28-day mortality (HR 1.27 95% CI (1.01-1.61), p = 0.048).

CONCLUSIONS: Our study demonstrates that daily serum sodium variability is an independent predictor of 28-day mortality in severe TBI patients. Further prospective investigations are necessary to confirm the significance of sodium variability in larger cohorts of TBI patients and test whether attenuating such variability confers outcome benefits to such patients.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Harrois A, Anstey JR, van der Jagt M, et al. Variability in Serum Sodium Concentration and Prognostic Significance in Severe Traumatic Brain Injury: A Multicenter Observational Study. Neurocrit Care. 2020. PMID: 33009658. doi:10.1007/s12028-020-01118-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。